During the past decade, CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez" #1 sponsor was "Centre Hospitalier Universitaire de Nice" with 12 trials, followed by "H. Lundbeck A/S" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Centre Hospitalier Universitaire de Nīmes" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez" #1 collaborator was "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator and "Erasme University Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez" are "Alzheimer Disease" (4 trials), "Alzheimer's Disease" (2 trials), "Chronic Cluster Headache" (2 trials), "Migraine" (2 trials) and "ALZHEIMER Disease" (1 trials). Many other conditions were trialed in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez" in a lesser frequency.

Most popular intervention types in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez" are "Drug" (14 trials), "Other" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eptinezumab" (3 trials), "Placebo" (3 trials), "Galcanezumab" (2 trials), "placebo" (2 trials) and "Arm A" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez" are 21 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".